Ginkgo Bioworks CEO Jason Kelly discusses the company’s work on autonomous labs and their impact on biopharma R&D.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.